What is the current valuation of the US hemianopsia market in 2024?

The overall market valuation was $499.8 Million in 2024. Read More

What is the projected market valuation for the US hemianopsia market by 2035?

The projected valuation for 2035 is $980.76 Million. Read More

What is the expected CAGR for the US hemianopsia market during the forecast period 2025 - 2035?

The expected CAGR for the market during this period is 6.32%. Read More

Which segment had the highest valuation in the US hemianopsia market in 2024?

Homonymous Hemianopsia had the highest valuation at $199.92 Million in 2024. Read More

What are the primary causes of hemianopsia in the US market?

The primary causes include Stroke, Brain Tumor, Traumatic Brain Injury, and Neurological Disorders. Read More

Which diagnostic method generated the highest revenue in the US hemianopsia market in 2024?

The Visual Field Test generated the highest revenue at $200.0 Million in 2024. Read More

What treatment type is expected to dominate the US hemianopsia market?

Surgery and Medication are expected to dominate, each valued at $199.92 Million in 2024. Read More

Who are the key players in the US hemianopsia market?

Key players include Novartis, Roche, Bausch Health, Allergan, Regeneron Pharmaceuticals, Santen Pharmaceutical, Hoya Corporation, and Carl Zeiss AG. Read More

What is the market valuation for Heteronymous Hemianopsia in 2024?

The market valuation for Heteronymous Hemianopsia was $149.94 Million in 2024. Read More

How does the market for Quadrantanopia compare to other segments in 2024?

Quadrantanopia had a valuation of $149.94 Million, similar to Heteronymous Hemianopsia in 2024. Read More

US Hemianopsia Market

US Hemianopsia Market Research Report By Type (Homonymous Hemianopsia, Heteronymous Hemianopsia, Quadrantanopia), By Cause (Stroke, Brain Tumor, Traumatic Brain Injury, Neurological Disorders), By Diagnostic Method (Visual Field Test, Optical Coherence Tomography, MRI) and By Treatment Type (Vision Therapy, Surgery, Medication) - Growth & Industry Forecast 2025 To 2035

Forecast Period

2025 - 2035

CAGR

6.32%

2024 Market Size

$ 499.8 Million

2035 Market Size

$ 980.76 Million

Pharmaceutical ● Updated August 2026 Report ID: MRFR/Pharma/18403-HCR | Pages: 100 | Author: Nidhi Mandole, Garvit Vyas

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Medical Device, BY Type (USD Million)
  1. 4.1.1 Homonymous Hemianopsia
  2. 4.1.2 Heteronymous Hemianopsia
  3. 4.1.3 Quadrantanopia
2. 4.2 Medical Device, BY Cause (USD Million)
  1. 4.2.1 Stroke
  2. 4.2.2 Brain Tumor
  3. 4.2.3 Traumatic Brain Injury
  4. 4.2.4 Neurological Disorders
3. 4.3 Medical Device, BY Diagnostic Method (USD Million)
  1. 4.3.1 Visual Field Test
  2. 4.3.2 Optical Coherence Tomography
  3. 4.3.3 MRI
4. 4.4 Medical Device, BY Treatment Type (USD Million)
  1. 4.4.1 Vision Therapy
  2. 4.4.2 Surgery
  3. 4.4.3 Medication
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Medical Device
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Medical Device
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Novartis (CH)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Roche (CH)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Bausch Health (CA)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Allergan (IE)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Regeneron Pharmaceuticals (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Santen Pharmaceutical (JP)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Hoya Corporation (JP)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Carl Zeiss AG (DE)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 US MARKET ANALYSIS BY TYPE
3. 6.3 US MARKET ANALYSIS BY CAUSE
4. 6.4 US MARKET ANALYSIS BY DIAGNOSTIC METHOD
5. 6.5 US MARKET ANALYSIS BY TREATMENT TYPE
6. 6.6 KEY BUYING CRITERIA OF MEDICAL DEVICE
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF MEDICAL DEVICE
9. 6.9 DRIVERS IMPACT ANALYSIS: MEDICAL DEVICE
10. 6.10 RESTRAINTS IMPACT ANALYSIS: MEDICAL DEVICE
11. 6.11 SUPPLY / VALUE CHAIN: MEDICAL DEVICE
12. 6.12 MEDICAL DEVICE, BY TYPE, 2024 (% SHARE)
13. 6.13 MEDICAL DEVICE, BY TYPE, 2024 TO 2035 (USD Million)
14. 6.14 MEDICAL DEVICE, BY CAUSE, 2024 (% SHARE)
15. 6.15 MEDICAL DEVICE, BY CAUSE, 2024 TO 2035 (USD Million)
16. 6.16 MEDICAL DEVICE, BY DIAGNOSTIC METHOD, 2024 (% SHARE)
17. 6.17 MEDICAL DEVICE, BY DIAGNOSTIC METHOD, 2024 TO 2035 (USD Million)
18. 6.18 MEDICAL DEVICE, BY TREATMENT TYPE, 2024 (% SHARE)
19. 6.19 MEDICAL DEVICE, BY TREATMENT TYPE, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY TYPE, 2025-2035 (USD Million)
  2. 7.2.2 BY CAUSE, 2025-2035 (USD Million)
  3. 7.2.3 BY DIAGNOSTIC METHOD, 2025-2035 (USD Million)
  4. 7.2.4 BY TREATMENT TYPE, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

US Hemianopsia Market Segmentation

US Hemianopsia Market By Type (USD Million, 2025-2035)

Homonymous Hemianopsia
Heteronymous Hemianopsia
Quadrantanopia

US Hemianopsia Market By Cause (USD Million, 2025-2035)

Stroke
Brain Tumor
Traumatic Brain Injury
Neurological Disorders

US Hemianopsia Market By Diagnostic Method (USD Million, 2025-2035)

Visual Field Test
Optical Coherence Tomography
MRI

US Hemianopsia Market By Treatment Type (USD Million, 2025-2035)

Vision Therapy
Surgery
Medication

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”